<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2001</study_start_year><condition>Dukes'C colorectal cancer which is removed curatively and surgically</condition><disease>Dukes'c Colorectal Cancer Which Is Removed Curatively And Surgically</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2609501</full_dataset_link><location>Japan</location><study_start_month>11</study_start_month><repository>ECRIN MDR</repository><study_status>Active, not recruiting</study_status></additional><is_claimable>false</is_claimable><name>Role of Thymidine Phosphorylase(TP), Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate synthase(TS)for Predicting the Prognosis and Therapeutic Effects of Doxifluridine, An Intermediate form of Capecitabine, in adjuvant therapy for postoperative Node positive colorectal cancer(DukesC); Findings from a multicenter Phase2 trial.</name><description>Interventions: chemotherapy(Doxifluridine:5’-DFUR)
Primary outcome(s): Disease-free survival
Study Design: Single arm Non-randomized</description><dates><creation>2001-11-15</creation></dates><accession>2609501</accession><cross_references><Japan Primary Registries Network>JPRN-C000000077</Japan Primary Registries Network></cross_references></HashMap>